|
Examining Elan’s Drug-Delivery Market as Industry and Commercial Interest in Drug Delivery has been Building Steadily
Dublin (PRWEB) January 31, 2006 -- Research and Markets (http://www.researchandmarkets.com/reports/c31711) has announced the addition of Elan Drug-Delivery Company Intelligence Report from Espicom Business Intelligence to their offering.
Industry and commercial interest in drug delivery has been building steadily. The benefits to patients can be seen in improved compliance and medical outcomes, while the pharmaceutical industry is able to extend patent protection through novel delivery regimes and bring new therapies to the market that would, previously, have been impossible. These detailed company reports bring into focus the companies which driving growth and innovation in drug delivery. Over 140 leading players are examined with details for Company Overview, Key Personnel, Key Milestones, Products/Technologies, Research Strategy, Agreements, Financial Data and Associated Companies (if any) provided for each.
Contents Include:
1. Key Personnel
| | - Company Overview
- Key Milestones
- Products/Technologies
- Research Activities
- Agreements
- Key Financial Data
- Competition
|
Elan Corporation began in 1969 with a vision to approach the challenge of drug delivery from an entirely new angle that of controlled absorption of a drug by the patient’s body. Today, Elan has become a fully integrated biopharmaceutical company, pioneering new research and development into Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, pain management and autoimmune diseases. It is focused on the discovery, development, and marketing of products and services in neurology, pain management, and autoimmune diseases and the development and commercialisation of products using its extensive range of proprietary drug-delivery technologies.
Elan is headquartered in Dublin, Ireland and employs approximately 4,500 people worldwide. Elan conducts its worldwide business, including operations relating to research and development, manufacturing and marketing, incorporated in Ireland, the US and the UK.
For more information visit http://www.researchandmarkets.com/reports/c31711
Laura Wood
Senior Manager
Research and Markets
Fax: +353 1 4100 980
# # #
|
